Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
Notizie di ultima ora e aggiornamenti in tempo reale
PepsiCo's Q1 Earnings Preview: Analysts Revise Forecasts Amidst Strong Performance

Anticipating Growth: PepsiCo's Strong Q1 Outlook
PepsiCo Gears Up for Q1 Earnings Release
PepsiCo, a global leader in beverages and snacks, is scheduled to unveil its financial results for the first quarter on Thursday, April 16, prior to the stock market's opening. This announcement is highly anticipated by investors and analysts alike, as it will provide crucial insights into the company's performance during the initial months of the year.
Analyst Projections: Earnings and Revenue Expected to Climb
According to consensus estimates compiled by Benzinga Pro, financial analysts are forecasting a positive quarter for the Purchase, New York-based conglomerate. The projected earnings per share stand at $1.54, marking an increase from the $1.48 reported in the corresponding period of the previous year. Furthermore, the company's quarterly revenue is expected to reach $18.92 billion, a significant jump from the $17.92 billion recorded last year, indicating healthy growth across its diverse product portfolio.
Building on Past Success: Strong Fourth Quarter Performance
The optimistic outlook for the first quarter follows a robust performance in the fourth quarter, where PepsiCo surpassed financial expectations. On February 3, the company reported strong fourth-quarter results and provided sales guidance for fiscal year 2026 that exceeded analyst estimates. This consistent outperformance has set a positive tone for future financial disclosures.
Market Reaction and Analyst Revisions
Despite the generally positive sentiment, PepsiCo's stock experienced a slight dip, closing at $155.88 on Monday, a marginal decrease of 0.8%. However, leading financial analysts have been actively revising their forecasts for PepsiCo, reflecting evolving market conditions and the company's recent operational achievements. Investors can access detailed analyst ratings and their accuracy rates on platforms like Benzinga's Analyst Stock Ratings page, allowing them to sort information by various criteria such as stock ticker, company name, and rating changes.
Expert Opinions: What Top Analysts Say About PepsiCo Stock
A review of ratings from some of Benzinga's most accurate analysts reveals a varied but generally positive sentiment towards PepsiCo. For instance, UBS analyst Peter Grom, with a 59% accuracy rate, reiterated a 'Buy' rating for the stock, though he adjusted his price target from $190 to $186 on April 7, 2026. Deutsche Bank's Steve Powers, holding a 64% accuracy rate, also maintained a 'Buy' rating while slightly reducing his price target from $176 to $169 on March 30, 2026. Conversely, Piper Sandler analyst Michael Lavery, with a 62% accuracy rate, upheld an 'Overweight' rating and increased his price target from $172 to $181 on March 12, 2026. TD Cowen's Robert Moskow (65% accuracy) maintained a 'Hold' rating and raised his price target from $162 to $165 on February 20, 2026, while Citigroup's Filippo Falorni (52% accuracy) kept a 'Buy' rating and elevated his price target from $170 to $182 on February 4, 2026. These diverse perspectives underscore the dynamic nature of market analysis and offer investors a comprehensive view before making investment decisions regarding PEP stock.

Author of "Secrets of the Millionaire Mind," focusing on the mindset and psychology of wealth.
Altri articoli
New Study Reveals Alarming Credit Card Habits Among Young Americans
A recent LendingTree study highlights that a significant portion of young Americans are making critical credit card errors, such as only paying minimum balances and mistakenly believing it improves credit scores. Many Gen Z individuals are relying on credit cards as emergency funds, often without knowing their interest rates, leading to escalating debt and financial vulnerability.
Di Chika UwazieSELLAS Life Sciences Advances Acute Myeloid Leukemia Treatment
SELLAS Life Sciences Group Inc. is making significant strides in its clinical programs for Acute Myeloid Leukemia (AML) treatments, GPS and SLS009. The company anticipates a pivotal year in 2026, driven by the final analysis of the Phase 3 REGAL trial for GPS and progress in the SLS009 program, which has shown promise in high-risk AML subtypes. Strong financial backing further supports these advancements.
Di Natalie PaceGoldman Sachs Raises Price Target for GE Vernova Stock Amidst Strong Q1 Expectations
Goldman Sachs has elevated its price target for GE Vernova (GEV) to $1,000 from $925, maintaining a 'Buy' rating. This adjustment reflects updated financial models and anticipation of robust Q1 earnings, particularly in gas turbine orders. Barclays also increased its price objective to $993, highlighting the growing power market.
Di Dave Ramsey